Product NDC: | 62037-866 |
Proprietary Name: | Enoxaparin Sodium |
Non Proprietary Name: | Enoxaparin Sodium |
Active Ingredient(s): | 150 mg/mL & nbsp; Enoxaparin Sodium |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 62037-866 |
Labeler Name: | Watson Pharma, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076684 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120127 |
Package NDC: | 62037-866-20 |
Package Description: | 10 BLISTER PACK in 1 CARTON (62037-866-20) > 1 SYRINGE in 1 BLISTER PACK > 1 mL in 1 SYRINGE |
NDC Code | 62037-866-20 |
Proprietary Name | Enoxaparin Sodium |
Package Description | 10 BLISTER PACK in 1 CARTON (62037-866-20) > 1 SYRINGE in 1 BLISTER PACK > 1 mL in 1 SYRINGE |
Product NDC | 62037-866 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Enoxaparin Sodium |
Dosage Form Name | INJECTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20120127 |
Marketing Category Name | ANDA |
Labeler Name | Watson Pharma, Inc. |
Substance Name | ENOXAPARIN SODIUM |
Strength Number | 150 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Heparin, Low-Molecular-Weight [Chemical/Ingredient],Low Molecular Weight Heparin [EPC] |